Dr Laura Gamble
Professor Fiona Matthews
| Comorbid health conditions and their impact on social isolation, loneliness, quality of life, and well-being in people with dementia: longitudinal findings from the IDEAL programme | 2024 |
|
Dr Laura Gamble
Professor Fiona Matthews
| Health conditions in spousal caregivers of people with dementia and their relationships with stress, caregiving experiences, and social networks: longitudinal findings from the IDEAL programme | 2024 |
|
Dr Laura Gamble
Professor Fiona Matthews
| Living well with dementia: An exploratory matched analysis of minority ethnic and white people with dementia and carers participating in the IDEAL programme | 2024 |
|
Dr Laura Gamble
Professor Fiona Matthews
| Are profiles of social, cultural, and economic capital related to living well with dementia? Longitudinal findings from the IDEAL programme | 2023 |
|
Dr Laura Gamble
| Dyadic influences on awareness of condition in people with dementia: findings from the IDEAL cohort | 2023 |
|
Dr Laura Gamble
| Evaluating ‘living well’ with mild-to-moderate dementia: Co-production and validation of the IDEAL My Life Questionnaire | 2023 |
|
Dr Laura Gamble
Professor Fiona Matthews
| Longitudinal Predictors of Informant-Rated Involvement of People with Dementia in Everyday Decision-Making: Findings from the IDEAL Program | 2023 |
|
Dr Laura Gamble
Professor Fiona Matthews
| Profiles of social, cultural, and economic capital as longitudinal predictors of stress, positive experiences of caring, and depression among spousal carers of people with dementia | 2023 |
|
Dr Laura Gamble
| Resilience in caregivers of people with mild-to-moderate dementia: findings from the IDEAL cohort | 2023 |
|
Dr Laura Gamble
| The associations between personality traits and quality of life, satisfaction with life, and well-being over time in people with dementia and their caregivers: findings from the IDEAL programme | 2023 |
|
Dr Laura Gamble
Professor Fiona Matthews
| "Living Well" Trajectories Among Family Caregivers of People With Mild-to-Moderate Dementia in the IDEAL Cohort | 2022 |
|
Dr Laura Gamble
Dr Holly Bennett
Professor Fiona Matthews
| A comparison of well-being of carers of people with dementia and their ability to manage before and during the COVID-19 pandemic: findings from the IDEAL study | 2022 |
|
Dr Laura Gamble
Professor Fiona Matthews
| Characteristics of people living with undiagnosed dementia: findings from the CFAS Wales study | 2022 |
|
Dr Laura Gamble
Dr Louise Allan
Professor Fiona Matthews
| Impact of COVID-19 on ‘Living Well’ with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort | 2022 |
|
Dr Laura Gamble
Professor Fiona Matthews
| Longitudinal Trajectories of Quality of Life Among People With Mild-to-Moderate Dementia: A Latent Growth Model Approach With IDEAL Cohort Study Data | 2022 |
|
Dr Holly Bennett
Dr Laura Gamble
Professor Fiona Matthews
| Minimal Impact of COVID-19 Pandemic on the Mental Health and Wellbeing of People Living With Dementia: Analysis of Matched Longitudinal Data From the IDEAL Study | 2022 |
|
Dr Laura Gamble
Professor Fiona Matthews
| Predictors of Awareness of Functional Ability in People with Dementia: The Contribution of Personality, Cognition, and Neuropsychiatric Symptoms – Findings from the IDEAL Program | 2022 |
|
Dr Laura Gamble
Professor Fiona Matthews
| Psychological Processes in Adapting to Dementia: Illness Representations Among the IDEAL Cohort | 2022 |
|
Dr Laura Gamble
Dr Yu-Tzu Wu
Professor Fiona Matthews
| The Use and Costs of Paid and Unpaid Care for People with dementia: Longitudinal Findings from the IDEAL cohort | 2022 |
|
Dr Laura Gamble
| Trajectories of socio-emotional functioning in early-stage dementia: implications for the individual with dementia and their family carer | 2021 |
|
Dr Laura Gamble
Professor Fiona Matthews
| Living Alone with Mild-To-Moderate Dementia: Findings from the IDEAL Cohort | 2020 |
|
Dr Laura Gamble
| Targeting Metabolic Activity in High-Risk Neuroblastoma Through Monocarboxylate Transporter 1 (MCT1) Inhibition | 2020 |
|
Dr Laura Gamble
| Inhibition of Polyamine Synthesis and Uptake Reduces Tumor Progression and Prolongs Survival in Mouse Models of Neuroblastoma | 2019 |
|
Livingstone Fultang
Dr Laura Gamble
| Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma | 2019 |
|
Dr Laura Gamble
| Suppression of the ATP-binding Cassette Transporter ABCC4 Impairs Neuroblastoma Tumour Growth and Sensitises to Irinotecan in Vivo | 2017 |
|
Dr Laura Gamble
| MYCN Promotes Neuroblastoma Malignancy by Establishing a Regulatory Circuit With Transcription Factor AP4 | 2016 |
|
Dr Laura Gamble
| Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression | 2016 |
|
Dr Laura Gamble
| Therapeutic Targeting of the MYC Signal by Inhibition of Histone Chaperone FACT in Neuroblastoma | 2015 |
|
Dr Jane Carr-Wilkinson
Bojidar Goranov
Dr Chris Redfern
Dr Laura Gamble
Professor John Lunec
et al. | Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression | 2011 |
|
Dr Lindi Chen
Dr Laura Gamble
Professor John Lunec
Professor Deborah Tweddle
| p53 is a direct transcriptional target of MYCN in neuroblastoma | 2010 |
|
